RecruitingPhase 2NCT06058546

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Clinical Trial of Efficacy and Safety of Jiuweihuaban Pill in the Treatment of Moderate to Severe Plaque Psoriasis(Syndrome of Blood-heat ).

Sponsor

Tasly Pharmaceutical Group Co., Ltd

Enrollment

180 participants

Start Date

Nov 23, 2023

Study Type

INTERVENTIONAL

Conditions

Plaque Psoriasis

Summary

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Jiuweihuaban Pill placebo, a drug called high dose Jiuweihuaban Pill, and others for people with plaque psoriasis. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGJiuweihuaban Pill placebo

Jiuweihuaban pill placebo 1 bag(12 g placebo per bag),p.o.,tid,for 12weeks.

DRUGlow dose Jiuweihuaban Pill

Low dose Jiuweihuaban pill 1 bag(3 g placebo per bag and 9 g Jiuweihuaban pill ),p.o.,tid,for 12weeks.

DRUGhigh dose Jiuweihuaban Pill

High dose Jiuweihuaban pill 1 bag(12 g Jiuweihuaban pill ),p.o.,tid,for 12weeks.

Locations(12)

Beijing traditional Chinese medicine hospital affiliated to Capital Medical University

Beijing, China

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Changchun, China

The First Affiliated Hospital of Hunan University of Chinese Medicine

Changsha, China

Chengdu Second People's Hospital

Chengdu, China

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Jinan, China

Yunnan Provincial Hospital of Traditional Chinese Medicine

Kunming, China

Nanyang First People's Hospital

Nanyang, China

The First Affiliated Hospital of China Medical University

Shenyang, China

Affiliated Hospital of Tianjin Institute of Traditional Chinese Medicine

Tianjin, China

First affiliated hospital of Wenzhou medical university

Wenzhou, China

The Second Affiliated Hospital of Xiamen Medical College

Xiamen, China

Xingtai people's hospital

Xingtai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06058546

Related Trials

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967383 locations

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT0477207963 locations

A Phase 3 Clinical Study of QL2106 Injection

NCT075116471 location

Modifying PEST for Psoriatic Arthritis Screening

NCT0638205129 locations

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT0729056936 locations